Cigna target upped to $263 from $221 by Citigroup

Maintains Buy
https://www.benzinga.com/stock/CI/ratings

Amgen target raised to $275 from $245 by Citigroup

Maintains Buy
https://www.benzinga.com/stock/AMGN/ratings

Johnson & Johnson target upped to $161 from $147 by Raymond James

Maintains Outperform
https://www.benzinga.com/stock/JNJ/ratings

Epizyme target upped to $35 from $25 by Citigroup

Maintains Buy
https://www.benzinga.com/stock/EPZM/rating

Abbott target raised to $104 from $95 by Stifel

Maintains Buy
https://www.benzinga.com/stock/ABT/ratings

Revance target raised to $39 frm $34 by Mizuho

Maintains Buy
https://www.benzinga.com/stock/RVNC/ratings

Evolent Health target upped to $16 from $10 by Cantor

Maintains Overweight
https://www.benzinga.com/stock/EVH/ratings